Search form

Latest News

Quidel’s Lyra® SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19; Also Receives CE Mark, Health Canada Authorization

Quidel Corporation (NASDAQ: QDEL) (“Quidel”) , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra® SARS-CoV-2 Assay has received expanded Emergency Use Authoriza...

Read More »


Are you a determined, optimistic, team player? Quidel is looking for talented innovators who want to be part of revolutionizing medical diagnostics.

View Current Job Openings


To place orders, get assistance with shipments, pricing or contract administration view our Customer Support page.

Visit our Technical Support page to get help with product specifications, supporting docs or general support issues.

NEW: Register at to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.